Molecular Imaging System enables real-time video observation.September 16, 2008 -
IVIS® Kinetic in vivo small animal imaging system allows researchers to visualize, track, quantify, and understand biological processes at molecular level as they occur in real-time, driving visual exploration and analysis of gene expression, cellular pathways, and drug response. It features isolation chamber which allows users to monitor conscious mice freely walking and performing tasks, and helps understand any drug candidate's potential performance in clinical studies.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
Caliper Life Sciences, Inc.
68 Elm Street
Hopkinton, MA, 01748
USA
Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
o New IVIS Kinetic System Extends Application Breadth of Market-Leading
IVIS Instrument Family
o Imaging Products Continue to Drive Revenue Growth
HOPKINTON, Mass., September 9, 2008 -- Caliper Life Sciences, Inc. (NASDAQ: CALP),
a leading provider of tools and services for drug discovery and life sciences research, today introduced the IVIS® Kinetic preclinical in vivo imaging system. The system enables researchers to non-invasively view biological events at the molecular level as they occur in real-time. The IVIS Kinetic system utilizes the latest developments in ultra-high sensitivity scientific cameras to add video capability to the company's existing line of preclinical, high sensitivity bioluminescence and fluorescence molecular optical imaging offerings. This additional capability will further advance cardiovascular, neurology, immunology and oncology distribution studies conducted using in vivo imaging.
With the launch of the IVIS Kinetic system, researchers are now able to visualize, track, quantify and understand biological processes in real time - as the action happens - driving visual exploration and analysis of gene expression, cellular pathways and drug response.
The IVIS Kinetic system features an isolation chamber that allows users to monitor
conscious mice freely walking and performing tasks. By capturing images and live video, at the molecular level, researchers can witness dynamic processes and reactions, enhancing the understanding of a drug candidate's potential performance in clinical studies. Specifically, by allowing researchers to view the real-time distribution of drugs and an animal model's responses to a compound, a more thorough understanding of a drug's potential can be assessed.
"The IVIS Kinetic imaging system provides a window for scientists to view biological
events as they happen," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "This system is another great example of how Caliper Life Sciences is helping pharma and biotech companies understand complex biological processes to accelerate the discovery of successful drug candidates."
Caliper's IVIS imaging systems have played a significant role in demonstrating the efficacy of various drugs, including Sutent® (Pfizer), Sprycel® (dasatinib) (Bristol-Myers Squibb), Tasigna® (Novartis), and Cubicin® (Cubist Pharmaceuticals).
Caliper offers a broad portfolio of imaging systems. For additional information or to order the IVIS Kinetic, please visit: http://www.caliperls.com/products/opt....
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling
researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.
|
|
|
|
|
|
|
| 
